Department of Psychiatry, Mackay Memorial Hospital Taitung Branch, Taitung; ; School of Medicine, Buddhist Tzu Chi University, Hualien;
Neuropsychiatr Dis Treat. 2013;9:397-401. doi: 10.2147/NDT.S40466. Epub 2013 Mar 26.
Depression is a major psychiatric disorder. The standard treatment for depression is antidepressant medication, but the responses to antidepressant treatment are only partial, even poor, among 30%-45% of patients. Refractory depression is defined as depression that does not respond to antidepressant therapy after 4 weeks of use. There is evidence that repetitive transcranial magnetic stimulation (rTMS) may exert effects in treating psychiatric disorder through moderating focal neuronal functions. High-frequency rTMS on the left prefrontal area and low-frequency rTMS on the right prefrontal area were shown to be effective in alleviating depressive symptoms. Given the statistically significant antidepressant effectiveness noted, the clinical application of rTMS as a depression treatment warrants further studies. Application of rTMS as an add-on therapy would be a practical research model. High-frequency (5-20 Hz) rTMS over the left dorsolateral prefrontal cortex was found to have a significant effect on medication-resistant depression. In the present study, we not only measured the acute antidepressant effect of rTMS during treatment and immediately after its completion but also evaluated participants 1 month after completion of the treatment protocol. Study participants were divided into two groups: an active rTMS group (n = 10) and a sham group (n = 10). The active rTMS group was defined as participants who received the rTMS protocol, and the sham group was defined as participants who received a sham rTMS procedure. A significant Hamilton Depression Rating Scale score reduction was observed in both groups after the fifth and tenth treatments. However, those in the active rTMS group maintained their improvement as measured one month after completion of the rTMS protocol. Participants who received active rTMS were more likely to have persistent improvement in depression scores than participants who received sham rTMS.
抑郁症是一种主要的精神障碍。抑郁症的标准治疗方法是抗抑郁药物治疗,但在 30%-45%的患者中,抗抑郁治疗的反应只是部分的,甚至是差的。难治性抑郁症定义为使用抗抑郁药物治疗 4 周后仍无反应的抑郁症。有证据表明,重复经颅磁刺激(rTMS)通过调节局部神经元功能可能对治疗精神障碍产生影响。左前额区域的高频 rTMS 和右前额区域的低频 rTMS被证明可以有效缓解抑郁症状。鉴于 noted 显著的抗抑郁效果,rTMS 在抑郁症治疗中的临床应用值得进一步研究。rTMS 的应用作为附加治疗将是一个实用的研究模型。左背外侧前额叶的高频(5-20 Hz)rTMS 被发现对药物抵抗性抑郁症有显著影响。在本研究中,我们不仅在治疗过程中和治疗完成后立即测量了 rTMS 的急性抗抑郁作用,还在治疗方案完成后 1 个月评估了参与者。研究参与者分为两组:主动 rTMS 组(n = 10)和假刺激组(n = 10)。主动 rTMS 组定义为接受 rTMS 方案的参与者,假刺激组定义为接受假 rTMS 程序的参与者。第五次和第十次治疗后,两组的汉密尔顿抑郁量表评分均显著降低。然而,在 rTMS 方案完成一个月后,主动 rTMS 组的参与者保持了他们的改善。与接受假 rTMS 的参与者相比,接受主动 rTMS 的参与者更有可能持续改善抑郁评分。